SCHEMBL13309116

SCHEMBL13309116

CBc1cnn2c(Nc3ccc(S(=O)(=O)NCCCn4ccnc4)cc3)cc(-c3ccccc3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.49
▸ KDM4E B2RXH2 5/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ MITF O75030 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HPGD P15428 1/20 0.44
▸ CYP19A1 P11511 4/20 0.44
▸ POLB P06746 2/20 0.44
▸ OPRK1 P41145 2/20 0.42
▸ PAOX Q6QHF9 2/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ ADRA2B P18089 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13885130 0.88 ALDH1A1 (0.48) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL14528759 0.85 IKBKB (0.42) KDM4EKMT2ANPC1MAPTRAB9A
SCHEMBL13309052 0.81 KDM4E (0.43) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL13309461 0.79 KDM4E (0.44) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL13309241 0.78 GSK3B (0.46) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL13308747 0.78 KDM4E (0.44) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL14528803 0.78 KMT2A (0.39) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL14528898 0.75 KDM4E (0.41) ALDH1A1KDM4EKMT2ANPC1RAB9A
SCHEMBL14528735 0.74 KDM4E (0.43) ALDH1A1KDM4EKMT2ANPC1MAPT
SCHEMBL13885081 0.74 GSK3B (0.53) ALDH1A1KDM4EKMT2ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934224-B1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORP (US) 2010-06-09 — — EP disclosed
Send feedback